| Year |
Citation |
Score |
| 2017 |
Meng B, Bentley K, Marriott AC, Scott PD, Dimmock NJ, Easton AJ. Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA. Virology Journal. 14: 138. PMID 28738877 DOI: 10.1186/s12985-017-0805-6 |
0.337 |
|
| 2016 |
Smith CM, Scott PD, O'Callaghan C, Easton AJ, Dimmock NJ. A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral. Viruses. 8. PMID 27556481 DOI: 10.3390/v8080237 |
0.361 |
|
| 2014 |
Marriott AC, Dove BK, Whittaker CJ, Bruce C, Ryan KA, Bean TJ, Rayner E, Pearson G, Taylor I, Dowall S, Plank J, Newman E, Barclay WS, Dimmock NJ, Easton AJ, et al. Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir. Plos One. 9: e94090. PMID 24709834 DOI: 10.1371/journal.pone.0094090 |
0.351 |
|
| 2014 |
Dimmock NJ, Easton AJ. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals? Journal of Virology. 88: 5217-27. PMID 24574404 DOI: 10.1128/JVI.03193-13 |
0.389 |
|
| 2012 |
Dimmock NJ, Dove BK, Scott PD, Meng B, Taylor I, Cheung L, Hallis B, Marriott AC, Carroll MW, Easton AJ. Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established. Plos One. 7: e49394. PMID 23251341 DOI: 10.1371/journal.pone.0049394 |
0.367 |
|
| 2012 |
Dimmock NJ, Dove BK, Meng B, Scott PD, Taylor I, Cheung L, Hallis B, Marriott AC, Carroll MW, Easton AJ. Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir. Antiviral Research. 96: 376-85. PMID 23041142 DOI: 10.1016/j.antiviral.2012.09.017 |
0.361 |
|
| 2011 |
Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ. Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo. Vaccine. 29: 6584-91. PMID 21762748 DOI: 10.1016/j.vaccine.2011.06.114 |
0.332 |
|
| 2011 |
Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ. Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. The Journal of General Virology. 92: 2122-32. PMID 21632569 DOI: 10.1099/vir.0.034132-0 |
0.329 |
|
| 2010 |
Meng B, Marriott AC, Dimmock NJ. The receptor preference of influenza viruses Influenza and Other Respiratory Viruses. 4: 147-153. PMID 20409211 DOI: 10.1111/j.1750-2659.2010.00130.x |
0.301 |
|
| 2008 |
Dimmock NJ, Rainsford EW, Scott PD, Marriott AC. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. Journal of Virology. 82: 8570-8. PMID 18579602 DOI: 10.1128/JVI.00743-08 |
0.323 |
|
| 2006 |
Dimmock NJ, Marriott AC. In vivo antiviral activity: Defective interfering virus protects better against virulent Influenza A virus than avirulent virus Journal of General Virology. 87: 1259-1265. PMID 16603528 DOI: 10.1099/vir.0.81678-0 |
0.356 |
|
| 2004 |
Noble S, McLain L, Dimmock NJ. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. Vaccine. 22: 3018-25. PMID 15297051 DOI: 10.1016/j.vaccine.2004.02.013 |
0.316 |
|
| 2003 |
Reading SA, Heap CJ, Dimmock NJ. A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progeny. Virology. 315: 362-72. PMID 14585339 |
0.311 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
Easton AJ, Scott PD, Edworthy NL, Meng B, Marriott AC, Dimmock NJ. A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine. 29: 2777-84. PMID 21320545 DOI: 10.1016/j.vaccine.2011.01.102 |
0.295 |
|
| 2015 |
Dimmock NJ, Easton AJ. Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases. Viruses. 7: 3768-88. PMID 26184282 DOI: 10.3390/v7072796 |
0.286 |
|
| 2005 |
Heap CJ, Reading SA, Dimmock NJ. An antibody specific for the C-terminal tail of the gp41 transmembrane protein of human immunodeficiency virus type 1 mediates post-attachment neutralization, probably through inhibition of virus-cell fusion. The Journal of General Virology. 86: 1499-507. PMID 15831963 DOI: 10.1099/vir.0.80414-0 |
0.277 |
|
| 2011 |
Scott PD, Meng B, Marriott AC, Easton AJ, Dimmock NJ. Defective interfering virus protects elderly mice from influenza. Virology Journal. 8: 212. PMID 21549019 DOI: 10.1186/1743-422X-8-212 |
0.277 |
|
| 2023 |
Dimmock NJ, Easton AJ. Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus. Viruses. 15. PMID 36851717 DOI: 10.3390/v15020504 |
0.259 |
|
| 2017 |
Gould PS, Easton AJ, Dimmock NJ. Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA. Viruses. 9. PMID 28934167 DOI: 10.3390/v9100269 |
0.257 |
|
| 2003 |
Hardy SA, Dimmock NJ. Valency of antibody binding to enveloped virus particles as determined by surface plasmon resonance. Journal of Virology. 77: 1649-52. PMID 12502884 DOI: 10.1128/JVI.77.2.1649-1652.2003 |
0.256 |
|
| 2004 |
Critchley P, Dimmock NJ. Binding of an influenza A virus to a neomembrane measured by surface plasmon resonance. Bioorganic & Medicinal Chemistry. 12: 2773-80. PMID 15110858 DOI: 10.1016/j.bmc.2004.02.042 |
0.251 |
|
| 2005 |
Cheung L, McLain L, Hollier MJ, Reading SA, Dimmock NJ. Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion. The Journal of General Virology. 86: 131-8. PMID 15604440 DOI: 10.1099/vir.0.80439-0 |
0.245 |
|
| 2003 |
Cleveland SM, McLain L, Cheung L, Jones TD, Hollier M, Dimmock NJ. A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion. The Journal of General Virology. 84: 591-602. PMID 12604810 DOI: 10.1099/vir.0.18630-0 |
0.238 |
|
| 2002 |
Khiytani DK, Dimmock NJ. Characterization of a human immunodeficiency virus type 1 pre-integration complex in which the majority of the cDNA is resistant to DNase I digestion. The Journal of General Virology. 83: 2523-32. PMID 12237436 DOI: 10.1099/0022-1317-83-10-2523 |
0.223 |
|
| 2017 |
Dimmock NJ, Easton AJ. Can defective interfering RNAs affect the live attenuated influenza vaccine? The Lancet. Infectious Diseases. 17: 1234-1235. PMID 29173876 DOI: 10.1016/S1473-3099(17)30637-0 |
0.197 |
|
| 2004 |
Dimmock NJ, Hardy SA. Valency of antibody binding to virions and its determination by surface plasmon resonance. Reviews in Medical Virology. 14: 123-35. PMID 15027004 DOI: 10.1002/rmv.419 |
0.18 |
|
| 2005 |
Heap CJ, Wang Y, Pinheiro TJ, Reading SA, Jennings KR, Dimmock NJ. Analysis of a 17-amino acid residue, virus-neutralizing microantibody. The Journal of General Virology. 86: 1791-800. PMID 15914858 DOI: 10.1099/Vir.0.80812-0 |
0.175 |
|
| 2005 |
Hollier MJ, Dimmock NJ. The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function. Virology. 337: 284-96. PMID 15913700 DOI: 10.1016/j.virol.2005.04.015 |
0.171 |
|
| 2005 |
Dimmock NJ. The complex antigenicity of a small external region of the C-terminal tail of the HIV-1 gp41 envelope protein: a lesson in epitope analysis. Reviews in Medical Virology. 15: 365-81. PMID 16106492 DOI: 10.1002/rmv.476 |
0.171 |
|
| 2003 |
Dimmock N. Clinical science not to be sneezed at Nature. 422: 379-380. DOI: 10.1038/422379A |
0.103 |
|
| Hide low-probability matches. |